Tumor specific delivery and therapy mediate by integrin β6-target immunoliposomes for β6-siRNA in colon carcinoma.

about

Although it's painful: The importance of stringent antibody validation.

P2860

Q48309547-C9C8BAED-6AFE-419B-BC82-B0B8B2510FDA

P2860

Tumor specific delivery and therapy mediate by integrin β6-target immunoliposomes for β6-siRNA in colon carcinoma.

Item

http://www.wikidata.org/entity/Q37709107

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Tumor specific delivery and th ...... r β6-siRNA in colon carcinoma.

@en

Tumor specific delivery and th ...... r β6-siRNA in colon carcinoma.

@nl

type

Item

label

Tumor specific delivery and th ...... r β6-siRNA in colon carcinoma.

@en

Tumor specific delivery and th ...... r β6-siRNA in colon carcinoma.

@nl

prefLabel

Tumor specific delivery and th ...... r β6-siRNA in colon carcinoma.

@en

Tumor specific delivery and th ...... r β6-siRNA in colon carcinoma.

@nl

P1476

Tumor specific delivery and th ...... r β6-siRNA in colon carcinoma.

@en

P2093

Cheng Kai

http://www.w3.org/2001/XMLSchema#string

Han Yong

http://www.w3.org/2001/XMLSchema#string

Jia Zhongming

http://www.w3.org/2001/XMLSchema#string

Li Zequn

http://www.w3.org/2001/XMLSchema#string

Liang Benjia

http://www.w3.org/2001/XMLSchema#string

Liu Song

http://www.w3.org/2001/XMLSchema#string

Niu Jun

http://www.w3.org/2001/XMLSchema#string

Wang Xiaohong

http://www.w3.org/2001/XMLSchema#string

Wang Xilong

http://www.w3.org/2001/XMLSchema#string

Yang Zhenlin

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor

Lyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencing.

Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma.

The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis.

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

RNAi therapeutics: principles, prospects and challenges.

Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability.

Integrin alpha(v)beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells

P304

85163-85175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.13209

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27835891

http://www.w3.org/2001/XMLSchema#string

P932

5356726

http://www.w3.org/2001/XMLSchema#string

Tumor specific delivery and therapy mediate by integrin β6-target immunoliposomes for β6-siRNA in colon carcinoma.

about

P2860

P2860

Tumor specific delivery and therapy mediate by integrin β6-target immunoliposomes for β6-siRNA in colon carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932